A股異動丨*ST河化復牌漲停 重組事項獲有條件通過
格隆匯12月12日丨*ST河化(000953.SZ)復牌漲停,報4.14元,總市值12.17億元。

昨日,中國證監會上市公司併購重組審核委員會召開2019年第67次工作會議,對公司重大資產出售併發行股份及支付現金購買資產並募集配套資金暨關聯交易事項進行了審核。根據會議審核結果,此次重組獲得有條件通過。公司擬向8名自然人發行股份及支付現金購買重慶南鬆醫藥科技股份有限公司93.41%的股份。重慶南鬆醫藥科技有限公司專業從事精細化工品、醫藥中間體、原料藥等產品的研究和製造。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.